Katja Weisel, MD Head of the Myeloma Center, University of Tubingen, discusses Outcomes Of The TOURMALINE-MM3 Study. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Outcomes Of The TOURMALINE-MM3 Study
Katja Weisel, MD Head of the Myeloma Center, University of Tubingen, discusses Outcomes Of The TOURMALINE-MM3 Study. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com